Skip to content

Clinical Study of Filtek™ Bulk Fill Posterior Restorative in Class I and II Restorations

A Randomized Multicenter Two-Arm Clinical Study to Evaluate the Safety and Efficacy of Filtek™ Bulk Fill Posterior Restorative in Class I and II Restorations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03764059
Enrollment
240
Registered
2018-12-04
Start date
2017-10-17
Completion date
2019-11-14
Last updated
2023-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries Class I, Dental Caries Class II

Keywords

dental restorative, Composite posterior restorative

Brief summary

Purpose of the Study:This study was to evaluate the 1 week, 1 year safety and effectiveness of dental composite resin (Filtek™ Bulk Fill Posterior Restorative) in restoring Class I and II dental cavities in posterior teeth.

Detailed description

This was a randomized, two- arm, non-inferiority study to evaluate the safety and clinical performance of resin composite, Filtek™ Bulk Fill. Test apparatus: Apparatus for Test: Filtek™ Bulk Fill Posterior Restorative Apparatus for Control: 3M™ ESPE™ Filtek™ Z350XT, was approved by CFDA in 2010 and had been in the market for 5 years with some validated clinical data. Sample Size of Subjects: Two-hundred forty (240) patients were expected to be recruited into the study and were randomly assigned to the test group and the control group according to the ratio of 1: 1; thus the number of cases in each group was 120. Finally, a total of 240 subjects were randomly enrolled in the study, including 120 subjects in the test group and 120 subjects in the control group, which met the required sample size. The study consisted of screening period (initial screening visit, post-preparation screening visit), 1-week follow-up visit and 1-year follow-up visit, during which all the tests required in the protocol would be conducted to select the subjects meeting the criteria for inclusion. The examination and evaluation of the initial screening period were supposed to be completed within 0.5 days. Then investigators would make an appointment with the subjects eligible for the initial screening for cavity preparation and tooth filling, the required time of which depended on the complexity of the tooth problem and would be completed within 0.5 days. Immediate evaluation of relevant indicators were offered to the subjects who were selected and qualified after preparation and patients with qualified score would continue to have the 1-week and 1-year follow-up visits. Subjects were randomly assigned to either the test group (Filtek™ Bulk Fill Posterior Repository) or the control group (Filtek™ Z350XT) in a central random manner, using the corresponding test product or control product to fill and restore posterior teeth defects (class I or class II cavities). Since all investigators were required to operate according to instructions, it was clear to them which product a subject was given. However, subjects and clinical evaluators were blinded regarding whether the test product (Filtek™ Bulk Fill Posterior Repository) or the control product (Filtek™ Z350XT) was used by the subjects. Immediately after restoration placement, at 1 week and 1 year postoperative, two or three clinical evaluators from each site performed the clinical assessment (the third more senior evaluator performed the assessment and determination if the first two evaluators were not in agreement) per China Technical Instruction and Guidance of Resin Composite Restoration Material For CFDA Registration (Technical Instruction and Guidance in short). The clinical acceptable rate of the restoration at 1 year was the primary endpoint in this study. AE/SAE were collected to evaluate the safety of Filtek™ Bulk Fill. Based on the assessment result, if the clinical acceptance rate of the two groups achieved the clinical acceptable rate defined in the protocol, it indicated that Filtek™ Bulk Fill was efficacious for class 1 and II restorations.

Interventions

DEVICEFiltek™ Bulk Fill Posterior Restorative

The subjects were assigned to either the investigational device (Filtek™ Bulk Fill Posterior Restorative) or the control device (Filtek™ Z350XT Universal Restorative) per web-based randomization system.

DEVICEFiltek™ Z350XT Universal Restorative

The subjects were assigned to either the investigational device (Filtek™ Bulk Fill Posterior Restorative) or the control device (Filtek™ Z350XT Universal Restorative) per web-based randomization system.

Sponsors

3M
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Male or female,18 to 70 years old (including 18 and 70 years) 2. Good health, no significant systemic disease; 3. Normal opening degree; 4. Molar (preferred) or premolar teeth 5. Cavity type with belongs to any of the following: 1) Class I, including the failed class I restoration which require to be repaired.; 2) Class II, including premolar and molar except the second molar (the failed class II restoration which require to be repaired is also included), and the gingival wall of cavity is above the free gingival margin coronally; 3) Class II cavity on the second molar when the third molar exists, and the gingival wall of cavity is above the free gingival margin coronally; 4) Class II, MO or MOD cavity on the second molar when the third molar does not exist (the failed class II restoration which require to be repaired is also included), and the gingival wall of cavity is above the free gingival margin coronally; 6. Cavity size: the buccolingual diameter of cavity is no less than the 1/3 and of the buccolingual cusp distance; 7. Occlusion with natural teeth; 8. Cavity depth: no less than 1/2 of dentin with a normal pulp status; 9. Be able to understand informed consent and to provide written inform consent ; 10. Be in good compliance with the protocol and willing to return to the site for follow up visits .

Exclusion criteria

1. Allergy to multiple medicines; allergy to resin or other polymer material; 2. Acute caries, severe periodontitis, salivary glands malfunction, dysfunction/disorder of TMJ (temporomandibular joint); 3. Poor oral hygiene, DMTF:18-34y \>4, 35-70y \>5; 4. Teeth with abnormal staining ; 5. Pathological abrasion (e.g. bruxism, clenching), acid corrosion, cracked-teeth and other non-caries diseases. 6. Abnormal occlusion; 7. Severe systemic or mental disorders; 8. Pregnant or intended to be pregnant (pregnant test is positive ) or breast feeding women; 9. Cavity do not meet the criteria based on the investigator's judgement; 10. Resin Composite is not an appropriate restoration for the subject 11. Pulp exposure or bottom of cavity is nearly close to the pulp; 12. Subjects who is not able to return for the one year follow-up visit because of going abroad or other reasons; 13. Subject is enrolled in other studies on investigational drug or device 14. Cannot tolerate rubber dam isolation. -

Design outcomes

Primary

MeasureTime frameDescription
Clinical Acceptance Rate of Restoration at 1 Year After Replacement1 Year after restorationAccording to Clinical Trial Guideline for Polymer-based Dental Restorative Materials (YY/T 0990-2015), the clinically acceptable definition of restoration at 1 year after replacement was as follows: The retention and fracture score of restoration at 1 year after replacement was A; the marginal fracture, the appearance and the marginal adaptationof restoration was A or B.

Countries

China

Participant flow

Participants by arm

ArmCount
Interventional
The experimental group (Filtek Bulk fill posterior restoration) .After restoration,subjects will return to site for follow up visit at 1 week and 1 year postoperative for further clinical assessments. Filtek bulk fill posterior restoration: The subjects will be assigned to either the investigational product (Filtek Bulk ) or the control product (Z350XT) per web-based randomization system. Immediately after restoration placement, at 1 week and 1 year postoperative, two evaluators from each site will perform an independent clinical assessment.
120
Observational
The control group (Filtek™ Z350XT Universal Restorative which was approved by CFDA in 2010 and has been in the market for 5 years with some validated clinical data).After restoration,subjects will return to the site for follow up visits at 1 week and 1 year postoperative for for further clinical assessments. Filtek™ Z350XT Universal Restorative: Filtek™ Z350XT Universal Restorative (Z350 XT) will serve as the control in this study.
120
Total240

Baseline characteristics

CharacteristicInterventionalObservationalTotal
Age, Continuous27.97 years
STANDARD_DEVIATION 6.65
28.12 years
STANDARD_DEVIATION 7.76
28.05 years
STANDARD_DEVIATION 10.22
Clinical diagnosis of caries119 participants120 participants239 participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
84 Participants81 Participants165 Participants
Sex: Female, Male
Male
36 Participants39 Participants75 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1200 / 120
other
Total, other adverse events
45 / 12036 / 120
serious
Total, serious adverse events
0 / 1200 / 120

Outcome results

Primary

Clinical Acceptance Rate of Restoration at 1 Year After Replacement

According to Clinical Trial Guideline for Polymer-based Dental Restorative Materials (YY/T 0990-2015), the clinically acceptable definition of restoration at 1 year after replacement was as follows: The retention and fracture score of restoration at 1 year after replacement was A; the marginal fracture, the appearance and the marginal adaptationof restoration was A or B.

Time frame: 1 Year after restoration

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Investigational Device/Experimental Group: Filtek™ Bulk Fill Posterior RestorativeClinical Acceptance Rate of Restoration at 1 Year After ReplacementAcceptable restoration120 Participants
Investigational Device/Experimental Group: Filtek™ Bulk Fill Posterior RestorativeClinical Acceptance Rate of Restoration at 1 Year After Replacementunacceptable restoration0 Participants
Control Device/Control Group: Filtek™ Z350XT Universal RestorativeClinical Acceptance Rate of Restoration at 1 Year After ReplacementAcceptable restoration119 Participants
Control Device/Control Group: Filtek™ Z350XT Universal RestorativeClinical Acceptance Rate of Restoration at 1 Year After Replacementunacceptable restoration1 Participants
p-value: <0.0001Cochran-Mantel-Haenszel

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026